Rating Change
RBC Capital reiterated its Sector Perform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on October 08, 2026.
reiterateNASDAQ:REGN
RBC Capital Reiterates Sector Perform Rating on Regeneron Pharmaceuticals, Inc. (REGN)
RBC Capital reiterated its Sector Perform rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on October 08, 2026.
At publication ·
What changed
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) · reiterate
- Firm
- RBC Capital
- Rating
- Sector Perform to Sector Perform
- Price at event
- $739.57
- Market capitalization
- $77.2B
At a glance
Key takeaways
- RBC Capital maintained a Sector Perform rating on Regeneron Pharmaceuticals on October 8, 2026, suggesting performance in line with its healthcare sector peers.
Market Context
Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $739.57 with a market capitalization of $77.2B. The stock has declined 5.8% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Regeneron Pharmaceuticals, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Regeneron Pharmaceuticals, Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 08, 2026 | RBC Capital | Sector Perform | N/A |
| Oct 07, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Oct 07, 2026 | Truist Securities | Buy | N/A |
| Oct 06, 2026 | JP Morgan | Overweight | N/A |
| Oct 01, 2026 | Argus Research | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View REGN Stock Page
Frequently Asked Questions
What does the Sector Perform rating mean for REGN?
A rating of Sector Perform from RBC Capital reflects the analyst's outlook on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the REGN forecast page.
